ABCELLERA BIOLOGICS INC (ABCL)

CA00288U1066 - Common Stock

2.72  +0.05 (+1.87%)

After market: 2.75 +0.03 (+1.1%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ABCL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15.74. This target is 478.57% above the current price.
ABCL was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ABCL.
In the previous month the buy percentage consensus was at a similar level.
ABCL was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.725.0514.2815.7429.40 - 85.66% 425.00% 478.57% 980.88%
Up and Down Grades
Date Firm Action Rating
2024-11-05 Benchmark Reiterate Hold
2024-11-05 Stifel Reiterate Buy -> Buy
2024-08-20 Benchmark Downgrade Buy -> Hold
2024-07-11 Keybanc Maintains Overweight -> Overweight
2024-05-08 Keybanc Maintains Overweight -> Overweight
2024-02-22 Benchmark Upgrade Hold -> Buy
2024-02-21 Stifel Maintains Buy -> Buy
2023-12-05 Keybanc Initiate Overweight
2023-08-31 Benchmark Maintains Buy -> Buy
2023-08-04 Goldman Sachs Maintains Buy -> Buy
2023-05-05 Credit Suisse Maintains Outperform
2023-02-28 Cowen & Co. Initiate Outperform
2023-02-22 BMO Capital Maintains Outperform
2023-02-22 Credit Suisse Reiterate Outperform
2023-01-06 SVB Leerink Maintains Outperform
2022-12-15 Goldman Sachs Initiate Buy
2022-11-16 Truist Securities Initiate Buy
2022-11-09 SVB Leerink Maintains Outperform
2022-08-10 Credit Suisse Maintains Outperform
2022-07-26 Piper Sandler Maintains Overweight
2022-05-11 SVB Leerink Maintains Outperform
2022-05-11 Piper Sandler Maintains Overweight
2022-02-25 SVB Leerink Maintains Outperform
2022-02-25 Credit Suisse Maintains Outperform
2021-12-21 Benchmark Initiate Buy
2021-11-19 Piper Sandler Initiate Overweight
2021-08-13 Credit Suisse Maintains Outperform
2021-05-14 Credit Suisse Maintains Outperform
2021-03-30 Stifel Maintains Buy
2021-02-08 SVB Leerink Maintains Outperform